Advantages SCHWIND SmartSurfACE

SmartSurfACE combines the benefits of touch-free TransPRK corneal refractive surgery with innovative SmartPulse technology, resulting in fast visual regeneration.

  • Touch-free – no suction, no cut, no incision
  • High cornea stability
  • Faster treatment, in a single step
  • Excellent clinical results
  • Economical: Easy to use, time-saving, low investment – no femtosecond laser required
SCHWIND SmartSurfACE Augenchirurg

SmartSurfACE technology

Touch-free technique

Touch-free technique

Unlike FemtoLASIK and lenticular extraction, with SmartSurfACE there is no suction or unnecessary pressure on the eye. It also normally leaves a higher residual stromal thickness, giving the patient higher safety; no corneal flap needs to be prepared, and there are no flap complications or dry eye syndrome. The stability of the cornea is retained.

Precise ablation

Precise ablation

SmartSurfACE corrects refractive errors by superimposing an aspheric ablation profile with a defined epithelial thickness profile. The user can choose a standard or individually modified profile. The Schwind Amaris laser then ablates corneal tissue through the epithelium in one step. The advantage of this is that the epithelium is removed more easily, precisely and evenly, and with a smaller diameter, than with PRK or LASEK.

SmartPulse

SmartPulse

Innovative SmartPulse technology gives an impressively smooth corneal surface. It is based on a new definition of the geometrical structure, the pulse definition and the pulse distribution for the ablation profile, with the goal of perfect use of spot geometry. The result is a faster visual recovery and better vision in the early postoperative phase.

SmartSurf potential laser candidates

Who is the SCHWIND SmartSurfACE method right for?

  • All eye laser surgery candidates who want to see clearly
  • Active and athletic people (contact sports, water sports, air sports)
  • People in professions where sharp vision is needed (such as pilots and policemen)
  • Patients with thin corneas
  • Patients with corneal pathologies or complex topographies

Inquire now!

Who is the SCHWIND SmartSurfACE method right for?

  • All eye laser surgery candidates who want to see clearly
  • Active and athletic people (contact sports, water sports, air sports)
  • People in professions where sharp vision is needed (such as pilots and policemen)
  • Patients with thin corneas
  • Patients with corneal pathologies or complex topographies

Inquire now!

SmartSurf potential laser candidates

What eye surgeons say about SmartSurfACE

  • The AMARIS platform abilities have established this system at the forefront for therapeutic corneal laser treatments. The latest advance has been the introduction of a new spot overlap algorithm (SmartPulse) giving a smoother surface with faster healing capabilities. Patients and surgeons like SmartSurfACE – the most comfortable no touch ablation technique - because it is quick and easy to do. In routine refractive correction, SmartSurfACE technology challenges the dominance of interfacial modalities such as LASIK and SMILE.

    Bruce Allan, MD
    Bruce Allan, MD UK
  • SmartSurfACE  is a no touch, all-laser procedure that has helped my patients feel better during and see appreciably better in the first few weeks after, compared with conventional aspheric PRK. My patients have been able to resume office work and enjoy performing their daily activities much earlier with SmartSurfACE and with only a few days delay compared to LASIK. It has also been a true savior when LASIK fails, consistently providing the great and fast results the patients were expecting to get.

    Dr. Shady Awwad, MD
    Dr. Shady Awwad, MD Lebanon
  • I saw patients with pain and discomfort after the PRK procedure, so I changed to LASIK surgery. I had to do with many complications like incomplete flaps, button holes or dislocated flaps. With the combination of TransPRK and SmartPulse, I can offer my patients a real no-touch procedure with much less pain especially using Mytomicin C, a very smooth corneal surface and a fast recovery, especially  of visual acuity. SmartSurfACE, at least in my practice, can compete with LASIK. We are very happy with it.

    Dr. Marcelo Fonseca, MD
    Dr. Marcelo Fonseca, MD Brasil
  • With SmartSurfACE we have an excellent technique to treat hyperopia using surface ablation, particularly for optical zone sizes larger than 6.7mm (up to 7.5mm) and total ablation zones of up to 9.2 mm. The biggest advantage is the surface quality after the laser treatment (three times smoother than after conventional PRK) and the quick visual recovery even in hyperopic eyes. At the contact lens removal eyes are seeing in average 20/32 or better.

    Dr. Emilio Juarez, MD
    Dr. Emilio Juarez, MD Spain
  • The recovery is even faster than LASIK on the first day. After two days, patients can read phones, check computer monitors and do many other things. After 4-5 days, when the contact lenses come out, the patients can drive again their car without glasses and they easily achieve 20/40 or better. So the wow effect has come back to refractive surgery. The patients are happy, the surgeons are happy because there are no complications from LASIK or flaps or lenticule. It’s truly stressless surgery – a paradigm shift in refractive surgery. SmartSurf is the way to go.

    Dr. David Lin, MD
    Dr. David Lin, MD Canada
  • Meanwhile 90 % of laser eye treatments are performed in our clinic with SmartSurfACE. The biggest advantage is the smoother surface after the laser treatment and the quick visual recovery. In 80 % of cases patients see 20/25 or better binocularly on day 4 after removal of the contact lens.  Predictability and efficacy is extraordinary so that less than 1 % of eyes need a second treatment. Furthermore, our workflow has been optimised using SmartSurfACE. The whole procedure takes about 7 minutes for both eyes.

    Dr. Diego de Ortueta, MD
    Dr. Diego de Ortueta, MD Germany
  • The AMARIS laser includes SmartPulse technology, what basically means, that it is smooth over the corneal surface. This is especially important, when you are doing treatments with what is called transepithelial PRK. TransPRK originally is done in a two-step procedure by other lasers. SmartSurfACE (TransPRK and SmartPulse Technology) removes the epithelium and treats the corneal shape all in one step. This makes it very simple. There is no hyperopic shift, there is no inconsistency in the myopic correction. SmartSurf is also very, very good for treatment of difficult cases. Cases with scars, cases with irregular corneas, and SmartSurfACE guided by corneal wavefront treatment is the best for treating difficult cases.

    Dr. Jerry Tan, MD
    Dr. Jerry Tan, MD Singpore
  • Today, SmartSurfACE (TransPRK and SmartPulse) constitutes about 35% of our refractive practice compared to  years ago when less than 1% of cases where treated - thanks to the new ablation pattern called SmartPulse providing a very big improvement in the smoothness of the corneal surface. We achieved optimal optical outcomes and we were also able to add several new patient target groups to our practice: those with thinner corneas, those without keratoconus but with unusual topographies, patients scared of the microkeratome.

    Dr. José Miguel Varas, MD
    Dr. José Miguel Varas, MD Ecuador

SmartSurfACE video statements

Dr. Marcelo Fonseca

Marcelo Fonseca, Laserview, Curitiba – Brasil

„I saw patients with pain and discomfort after the PRK procedure, so I changed to LASIK surgery. I had to do with many complications like incomplete flaps, button holes or dislocated flaps. SmartSurfACE, at least in my practice, can compete with LASIK. We are very happy with it.“

Dr. David Lin

David Lin, MD, Pacific Eye Laser Centre, Vancouver – Canada*

„The patients are happy, the surgeons are happy because it’s less stress and no complications from LASIK or flaps or lenticule. It’s truly stressless surgery – a paradigm shift in refractive surgery. SmartSurfACE is the way to go.“

*recorded by MingWang Medicals, China

Dr. Diego de Ortueta

Diego de Ortueta, MD, Aurelios Eye Clinic Recklinghausen – Germany*

„At our clinic more than 90% of cases are currently performed with SmartSurf ACE (TransPRK and SmartPulse Technology). I’m happy because the results are very predictable and the safety is very high.“

*recorded by MingWang Medicals, China

Dr. Jerry Tan

Jerry Tan, MD, Jerry Tan Eye Surgery – Singapore*

„SmartSurfACE (TransPRK and SmartPulse Technology) removes the epithelium and treats the corneal shape all in one step. This makes it very simple. There is no hyperopic shift, there is no inconsistency in the myopic correction.“

*recorded by MingWang Medicals, China

Dr. José Miguel Varas

Dr. José Miguel Varas, Centro Oftálmico Varas Samaniego, Guayaquil – Ecuador

„Today, SmartSurfACE (TransPRK and SmartPulse) constitutes about 35% of our refractive practice compared to  years ago when less than 1% of cases where treated – thanks to the new ablation pattern called SmartPulse providing a very big improvement in the smoothness of the corneal surface. “

Scientific publications

Here you can find scientific publications on the subject of SmartSurfACE (TransPRK) by internationally known refractive surgeons.

Single-Step Transepithelial PRK vs Alcohol-Assisted PRK in Myopia and Compound Myopic Astigmatism Correction. Kaluzny BJ, Cieslinska I, Mosquera SA, Verma S. Medicine (Baltimore). 95(6):e1993. February 2016.

Schwind-ErgebnisseMore information

One-Step Transepithelial Photorefractive Keratectomy With Mitomycin C as an Early Treatment for LASIK Flap Buttonhole Formation. Abdulaal MR, Wehbe HA, Awwad ST. Journal of Refractive Surgery. 31(1):48-52, January 2015.

Schwind-ErgebnisseMore information

Single-step transepithelial asla (SCHWIND) with mitomycin-C for the correction of high myopia: long term follow-up. Ioannis M. Aslanides, Panagiotis N. Georgoudis, Vasilis D Selimis, Achyut N Mukherjee. Clinical Ophthalmology, 2014 (9): 33-41.

Schwind-ErgebnisseMore information

On-line pachymetry outcome of ablation in aberration free mode TransPRK. Adib-Moghaddam S, Arba-Mosquera S, Salmanian B, Omidvari AH, Noorizadeh F. European Journal of Ophthalmology. 23;24(4):483-489. June 2014

Schwind-ErgebnisseMore information

Spectral OCT with speckle contrast reduction for evaluation of the healing process after PRK and transepithelial PRK. Kaluzny B J, Szkulmowski M, Bokowska DM, Wojtkowski M, Gora M, Wojtkowski M. Biomedical Optics Express. 5(4):1089-1098. April 2014

Schwind-ErgebnisseMore information

Theoretical analyses of the refractive implications of trans-epithelial PRK ablations. Arba Mosquera S, Awwad ST. British Journal of Ophthalmology. 97(7):905-911. July 2013.

Schwind-ErgebnisseMore information

Consecutive myopia correction with transepithelial versus alcohol-assisted photorefractive keratectomy in contralateral eyes: One-year results. M. H. A. Luger, MD; T. Ewering, Dipl-Ing (FH); S.Arba-Mosquera, MSc, PhD. Journal of Cataract & Refractive Surgery. 38(8):1414-1423. August 2012.

Schwind-ErgebnisseMore information

Comparison of single-step reverse transepithelial all-surface laser ablation (ASLA) to alcohol-assisted photorefractive keratectomy. I. M. Aslanides, S. Padroni, S. Arba Mosquera, A. Ioannides, A. Mukherjee. Clinical Ophthalmology. 2012; 6:973-980.

Schwind-ErgebnisseMore information

Simultaneous aspheric wavefront-guided transepithelial photorefractive keratectomy and phototherapeutic keratectomy to correct aberrations and refractive errors after corneal surgery. M. Camellin, MD; S. Arba Mosquera, MSc. Journal of Cataract & Refractive Surgery. 36(7):1173-1180. July 2010.

Schwind-ErgebnisseMore information

Transepithelial photorefractive keratectomy: Clinical Results. Fadlallah A, Fahed D, Khalil K, Dunia I, Menassa J, El Rami H, Chlela E, Fahed S. Journal of Cataract & Refractive Surgery. 37(10):1852-1857. October 2011.

Schwind-ErgebnisseMore information

SCHWIND AMARIS 1050RS excimer laser

The SCHWIND AMARIS product family

The SCHWIND AMARIS TotalTech excimer laser generation is an established leader in eye laser surgery technology and continues to set new standards on the market. The product family comprises three variants with different pulse rates and eye-tracking features, the AMARIS 1050RS, AMARIS 750S and AMARIS 500E. All AMARIS lasers deliver impressive precision and speed. That means a high level of safety for patients, fast treatment times, and easy, comfortable handling for the refractive surgeon during the individual treatment steps.

SCHWIND eye-tech-solutions:
Specialists in good vision

We are an owner-operated family company specializing in refractive surgery and therapeutic corneal surgery. Founded in 1958, today SCHWIND eye-tech-solutions has grown from an ophthalmologic supplier to the eye laser surgery technology leader.

Our strategy is focused on long-term doctor and patient satisfaction, and we are able to pursue this course rigorously, since as a family company we are beholden neither to share prices nor to shareholder value. Our solutions are based on the deep specialist knowledge of our staff, their long experience, and close collaboration with our users.

Over three years of research and development go into a new Schwind high-tech laser. Sophisticated quality management throughout the entire development process ensures high safety for patient and physician. Before approval, eye surgeons examine whether the new laser generation meets the requirements of clinical use, and extensive clinical studies are done. During the entire life cycle of a laser generation, it is continuously updated to the latest standards in close consultation with users.

Patients can be sure that the technological and ergonomic quality of a Schwind laser is always at the highest level. Today SCHWIND technology is in use in 125 countries, with over 1500 laser systems installed worldwide.

Information material

The video provides information about the new SmartSurfACE procedure – the gentle, safe, and new surface treatment method from SCHWIND.

Schwind-Smart-Surf-Produktflyer-EN

The brochure offers details on the new SmartSurfACE procedure and the broad range of treatment possibilities.

PDF-Download